Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Metabolism of [14C] BMS-955176 in Healthy Males
NCT02206711Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Aug 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of BMS-955176 in human immunodeficiency virus infection (HIV) (2 arms), sponsored by ViiV Healthcare. Primary endpoints: Pharmacokinetics (AUC, Cmax) and Extent of elimination (% Total Radioactivity recovery). Started Aug 2014; status: completed.
02
Drugs
BMS-955176
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02206711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206711.